<WIRE> Hera Med (ASX:HMD) Shares Surge in Biggest Intraday Rise in Three Months Following Strategic Partnership

Shares of Hera Med (ASX:HMD) have seen a significant rise of as much as 15% to A$0.023, marking their largest intraday percentage gain since December 18, 2023.

This lift of stock also puts the company at its highest level since February 28.

The spike in stock comes following the company’s recent strategic partnership agreement with FemBridge, a U.S.-based maternal solutions organization.

The aim of this agreement is to develop a scalable maternal health solution.

‘We anticipate achieving commercial milestones in the immediate future, with a steady growth trajectory expected throughout the remainder of 2024,’ say co-founders Traci Quillen and Maggie Huether.

The company has also seen a rise in trading volume, with about 911,410 shares changing hands, versus the 30-day average volume of 258,305 shares.

Despite the recent rise, the company’s stock is down 0.9% so far this year, as of the last close.

Hera Med (ASX:HMD) is a provider of pregnancy monitoring solutions.

View full chart on Save $30 on a Pro or Premium TradingView account

Save $30 on a Pro or Premium TradingView account

Supported by

<SPON> Trade share CFDs with Plus500

Global online trading services company, Plus500:

Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.

Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.


Subscribe to the newsletter

Receive whispers every day in your inbox.